Literature DB >> 31204605

Short-term effectiveness of conservative therapies in pain, quality of life, and sleep in patients with temporomandibular disorders: A randomized clinical trial.

Camila Maria Bastos Machado de Resende1, Fernanda Gondim Lemos de Oliveira Medeiros1, Cássia Renata de Figueiredo Rêgo1, Andressa de Sousa Leite Bispo1, Gustavo Augusto Seabra Barbosa1, Erika Oliveira de Almeida1.   

Abstract

Objective: To evaluate, in the short term, the effectiveness of conservative therapies in pain, quality of life, and sleep in TMD patients.
Methods: Eighty-nine TMD patients diagnosed by RDC-TMD were distributed in occlusal splints (OS; n= 24), manual therapy (MT; n= 21), counseling (C; n= 19), and OS associated with C (OSC; n= 25) therapy groups. Data collection was performed at baseline and within one month by VAS (pain), PSQI (sleep quality -SQ), WHOQOL-BREF (Quality of life - QL) and OHIP-14 (quality of life related to oral health -QLOH). The Split Plot ANOVA test was used to observe the difference between groups and over time.
Results: All therapies were effective over time, improving pain (p< .001), SQ (p=.001), QLOH (p< .001), and QL (p= .006), but not between them.Discussion: The therapies were effective in improving pain, SQ, and quality of life; however, no therapeutic group was superior to the other.

Entities:  

Keywords:  OHIP; PSQI; Temporomandibular joint disorders; VAS; WHOQOL; pain; quality of life; sleep wake disorders

Year:  2019        PMID: 31204605     DOI: 10.1080/08869634.2019.1627068

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  8 in total

Review 1.  Psychological therapies for temporomandibular disorders (TMDs).

Authors:  Chris Penlington; Charlotte Bowes; Greig Taylor; Adetunji Adebowale Otemade; Paula Waterhouse; Justin Durham; Richard Ohrbach
Journal:  Cochrane Database Syst Rev       Date:  2022-08-11

2.  Adhesive dentistry sensory stimulus technique as a neuromechanism for the treatment of orofacial pain associated to temporomandibular disorders: Case study.

Authors:  Miguel Pais Clemente; Asdrúbal Pinto; Fernando Milheiro; Teresa F Costa; Andre Moreira; Ricardo Vardasca; Pedro A Pereira; Joaquim Mendes; M Dulce Madeira; José Manuel Amarante
Journal:  J Oral Biol Craniofac Res       Date:  2020-01-18

3.  Comparative evaluation of occlusal splint therapy and muscle energy technique in the management of temporomandibular disorders: A randomized controlled clinical trial.

Authors:  Hardik K Ram; Darshana N Shah
Journal:  J Indian Prosthodont Soc       Date:  2021 Oct-Dec

4.  The Efficacy of Neck and Temporomandibular Joint (TMJ) Manual Therapy in Comparison With a Multimodal Approach in the Patients with TMJ Dysfunction: A Blinded Randomized Controlled Trial.

Authors:  Khaled Rezaie; Ali Amiri; Esmaeil Ebrahimi Takamjani; Gholamreza Shirani; Saman Salehi; Leila Alizadeh
Journal:  Med J Islam Repub Iran       Date:  2022-05-04

5.  Nonpharmacological Interventions for Pain in Patients with Temporomandibular Joint Disorders: A Systematic Review.

Authors:  Liliana Argueta-Figueroa; Luis Angel Flores-Mejía; Beatriz Xóchitl Ávila-Curiel; Blanca Irma Flores-Ferreyra; Rafael Torres-Rosas
Journal:  Eur J Dent       Date:  2022-03-08

6.  Factors associated with the oral health-related quality of life of patients with temporomandibular disorder at the final follow-up visit: a cross-sectional study.

Authors:  Prangtip Potewiratnanond; Nareudee Limpuangthip; Varangkana Karunanon; Ansaya Buritep; Athitaya Thawai
Journal:  BDJ Open       Date:  2022-10-02

Review 7.  Temporomandibular Disorders: Current Concepts and Controversies in Diagnosis and Management.

Authors:  Dion Tik Shun Li; Yiu Yan Leung
Journal:  Diagnostics (Basel)       Date:  2021-03-06

8.  The Application of Manual Techniques in Masticatory Muscles Relaxation as Adjunctive Therapy in the Treatment of Temporomandibular Joint Disorders.

Authors:  Piotr Urbański; Bartosz Trybulec; Małgorzata Pihut
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.